Description

The HOYA iSert PY-60AD is a specialized intraocular lens (IOL) designed for use in cataract surgery. As a monofocal, aspheric lens, it serves as a replacement lens implanted in the eye's capsular bag, providing clear vision post-surgery. Manufactured by HOYA, this lens is crafted from hydrophobic acrylic material, ensuring a glistening-free experience with its proprietary aspheric optic design.

Key Features

• Optic Design: The lens features a biconvex, aberration-correcting optic with a 360-degree square edge, enhancing visual clarity and reducing optical aberrations.
• Haptic Design: Equipped with a modified C-loop configuration, the haptics are made from blue PMMA and chemically bonded to the optic, providing stability and precise positioning within the eye.
• Size Specifications: The optic diameter measures 6.0 mm, and the overall length is 12.5 mm, with a power range from +6.00 to +30.00 diopters in 0.50 D increments.

Light Management

The HOYA iSert PY-60AD offers two color options: yellow, which includes a blue light filter, and clear, which does not. Both versions come with a UV filter, providing protection against harmful light exposure.

Advanced Delivery System

A standout feature of this lens is its fully preloaded iSert injector system. This system simplifies the implantation process by eliminating the need for cleaning and sterilizing reusable injectors. The injector tip has an outer diameter of 1.89 mm, allowing for a minimal incision size of less than 2.75 mm, promoting quicker recovery and reduced surgical impact.

Longevity and Reliability

Composed of 97% soft acrylic and 3% PMMA, the lens is designed for long-term use, with an expected lifetime of 20 years. It is intended for in-the-bag fixation, providing reliable performance without the need for replacement unless medically necessary.

Clinical Considerations

The HOYA iSert PY-60AD is suitable for adult patients undergoing cataract surgery. While there are no known contraindications, potential adverse events may include common surgical risks such as wound leak, dry eye syndrome, and changes in intraocular pressure. Surgeons should consider individual patient conditions when selecting this lens.

Proven Track Record

Since its launch in 2007, over 10 million of these lenses have been implanted worldwide, demonstrating a strong track record of clinical success and patient satisfaction. Detailed preparation instructions for the injector are provided with the product, ensuring proper handling and optimal outcomes.